148 related articles for article (PubMed ID: 21188446)
21. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
[TBL] [Abstract][Full Text] [Related]
22. Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.
McVernon J; Johnson PD; Pollard AJ; Slack MP; Moxon ER
Arch Dis Child; 2003 May; 88(5):379-83. PubMed ID: 12716702
[TBL] [Abstract][Full Text] [Related]
23. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
[TBL] [Abstract][Full Text] [Related]
24. Haemophilus influenzae type b conjugate vaccines.
Kelly DF; Moxon ER; Pollard AJ
Immunology; 2004 Oct; 113(2):163-74. PubMed ID: 15379976
[TBL] [Abstract][Full Text] [Related]
25. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
Ladhani S; Slack MP; Heys M; White J; Ramsay ME
Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness of Haemophilus influenzae type b conjugate vaccines in a high risk population measured using immunization register data.
Markey P; Krause V; Boslego JW; Coplan PM; Dargan JM; Kaplan KM
Epidemiol Infect; 2001 Feb; 126(1):31-6. PubMed ID: 11293680
[TBL] [Abstract][Full Text] [Related]
28. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.
Madhi SA; Petersen K; Khoosal M; Huebner RE; Mbelle N; Mothupi R; Saloojee H; Crewe-Brown H; Klugman KP
Pediatr Infect Dis J; 2002 Apr; 21(4):315-21. PubMed ID: 12075763
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.
Madhi SA; Kuwanda L; Saarinen L; Cutland C; Mothupi R; Käyhty H; Klugman KP
Vaccine; 2005 Dec; 23(48-49):5517-25. PubMed ID: 16107294
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada.
Wenger JD
Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S132-6. PubMed ID: 9781746
[TBL] [Abstract][Full Text] [Related]
32. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
[TBL] [Abstract][Full Text] [Related]
33. Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).
Romero-Steiner S; Fernandez J; Biltoft C; Wohl ME; Sanchez J; Feris J; Balter S; Levine OS; Carlone GM
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1115-9. PubMed ID: 11687449
[TBL] [Abstract][Full Text] [Related]
34. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
35. Increase in genetic diversity of Haemophilus influenzae serotype b (Hib) strains after introduction of Hib vaccination in The Netherlands.
Schouls LM; van der Ende A; van de Pol I; Schot C; Spanjaard L; Vauterin P; Wilderbeek D; Witteveen S
J Clin Microbiol; 2005 Jun; 43(6):2741-9. PubMed ID: 15956392
[TBL] [Abstract][Full Text] [Related]
36. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
37. Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B.
Anderson EL; Frey S; Geldmacher K; Radley D; Lee A; Donnelly J; Mendelman PM; Dargan JM; Kaplan KM
Pediatr Infect Dis J; 2002 Apr; 21(4):350-2. PubMed ID: 12075771
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of antibody response to Haemophilus influenzae type b vaccines. Pennridge Pediatric Associates.
Madore DV; Johnson-Kraines CL; Rothstein EP; Smith DH
Curr Med Res Opin; 1999; 15(2):105-12. PubMed ID: 10494493
[TBL] [Abstract][Full Text] [Related]
39. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
[TBL] [Abstract][Full Text] [Related]
40. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia.
Cimaz R; Mensi C; D'Angelo E; Fantola E; Milone V; Biasio LR; Carnelli V; Zanetti AR
J Infect Dis; 2001 Jun; 183(12):1819-21. PubMed ID: 11372038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
